LNAs (Qiagen) were designed to target SNORA73 and the SNHG3 lncRNA, or GFP as a control. pGFP-C-shLENTI lentiviral shRNA constructs (Origene TR30023) were designed to target hamster SNHG3 lncRNA or GFP as a control. See Supplementary Table
2. For LNA knockdown experiments in NIH 3T3 cells, 4.0 × 10
4 cells were seeded per well in a 6-well dish and transfected the following day with 25 nM LNA using
Lipofectamine 3000 (ThermoFisher L3000015). SNHG3 and SNORA73 expression and palmitate-induced cell death were analyzed 48 h following transfection. For LNA knockdown in CHO cells, 2.5 × 10
5 cells were plated in 6-cm dishes and transfected the next day with 25 nM LNA using
Lipofectamine 3000. For LNA knockdown in primary human fibroblasts, 5.0 × 10
4 cells were plated in 6-well plates, or 1.5 × 10
5 cells were seeded in 6-cm dishes. Cells were transfected with 25 nM LNA the following day using
Lipofectamine 3000. For shRNA transduction experiments, virus was harvested from
HEK293T cells (ATCC CRL-3216) that were transfected using
Lipofectamine 3000 with shRNA constructs and Mission helper plasmids (Sigma SHP001). 5.0 × 10
5 CHO cells were seeded in 6-cm dishes, grown for 24 h, and transduced with shSCR or shSNHG3 lentiviral particles. After expansion of the population, the top 20 percent of cells were flow-sorted and maintained as the transduced population.
Sletten A.C., Davidson J.W., Yagabasan B., Moores S., Schwaiger-Haber M., Fujiwara H., Gale S., Jiang X., Sidhu R., Gelman S.J., Zhao S., Patti G.J., Ory D.S, & Schaffer J.E. (2021). Loss of SNORA73 reprograms cellular metabolism and protects against steatohepatitis. Nature Communications, 12, 5214.